REPRINT: International, multicenter randomized preclinical trials in translational stroke research: It is time to act

Stroke

Volumn 43, Issue 6, 2012, Pages 1453-1454

  Dirnagl, Ulrich ^a   Fisher, Marc ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

animal models; neuroprotection; therapy

Indexed keywords

AX 200; BIOLOGICAL MARKER; NEUROPROTECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

BIOSTATISTICS; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DEATH; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; MORTALITY; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PEER REVIEW; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STROKE; TRANSLATIONAL RESEARCH; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84861648915     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.653709     Document Type: Editorial

References (11)

1. Bath PM, Macleod MR, Green AR. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke. 2009 Dec;4(6):471-9.
2. Dirnagl U. Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab. 2006, 26(12):1465-78.
3. Dirnagl U, Macleod MR. Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice. Br J Pharmacol. 2009 Aug;157(7):1154-6.
4. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis. 2008;25:268-78.
5. England TJ, Gibson CL, Bath PM. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. Brain Res Rev. 2009; 62(1):71-82.
6. Howells DW, Porritt MJ, Rewell SS, O'Collins V, Sena ES, van der Worp HB, Traystman RJ, Macleod MR. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:1412-31.
7. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 8(6): e1000412.
8. Lemon R, Dunnet SB. Surveying the literature from animal experiments. Critical reviews may be helpful-not systematic ones BMJ. 2005 April 30; 330(7498): 977-978.
9. Sygnis, Press Release Dec 15., 2011; http://www.sygnis.de/e740/e738/ e2094/files2095/PR-AX200-PhII-Results-eng.pdf.
10. van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007;130(Pt 12):3063-74
11. Vosler PS, Chen J. Potential molecular targets for translational stroke research. Stroke. 2009;40 (3 Suppl):S119-20.